Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state

Brain Research

Volumn 1350, Issue , 2010, Pages 167-175

  Victoriano, Montserrat ^a,b,c   De Beaurepaire, Renaud ^c   Naour, Nadia ^d,e   Guerre Millo, Michèle ^d,e   Quignard Boulangé, Annie ^a,b   Huneau, Jean François ^a,b   Mathé, Véronique ^a,b   Tomé, Daniel ^a,b   Hermier, Dominique ^a,b  

^a INRA Institut National de la Recherche Agronomique   (France)

^b AGROPARISTECH   (France)

^c Centre Hospitalier Paul Guiraud   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSERM   (France)

Author keywords

Adipose tissue; Antipsychotic; Cytokine; Inflammation; Lipid metabolism; Olanzapine

Indexed keywords

HALOPERIDOL; INTERLEUKIN 1BETA; OLANZAPINE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE TRANSPORT; INFLAMMATION; LIPID METABOLISM; LIVER; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CYTOKINES; GLUCOSE; HALOPERIDOL; IMMUNOASSAY; INFLAMMATION; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 77956180058     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.05.060     Document Type: Article

References (42)

1. D.B. Allison, J.L. Mentore, M. Heo, L.P. Chandler, J.C. Cappelleri, and M.C. Infante Antipsychotic-induced weight gain: a comprehensive research synthesis Am. J. Psychiatry 156 1999 1686 1696
2. T. Baptista Body weight gain induced by antipsychotic drugs: mechanisms and management Acta Psychiatr. Scand. 100 1999 3 16
3. T. Baptista, E. Araujo de Baptista, N.M. Ying Kin, S. Beaulieu, D. Walker, and R. Joober Comparative effects of the antipsychotics sulpiride or risperidone in rats: I. Bodyweight, food intake, body composition, hormones and glucose tolerance Brain Res. 957 2002 144 151
4. T. Baptista, E.A. de Baptista, J. Lalonde, J. Plamondon, N.M. Kin, and S. Beaulieu Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2004 1305 1311
5. D. Birkas Kovats, E. Palik, G. Faludi, and K. Cseh Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics Neuropsychopharmacol. Hung. 7 2005 132 139
6. D. Brustolim, R. Ribeiro-dos-Santos, R.E. Kast, E.L. Altschuler, and M.B. Soares A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice Int. Immunopharmacol. 6 2006 903 907
7. R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, and C. Rouault Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 54 2005 2277 2286
8. R. Cancello, J. Tordjman, C. Poitou, G. Guilhem, J.L. Bouillot, and D. Hugol Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity Diabetes 55 2006 1554 1561
9. Consensus development conference on antipsychotic drugs and obesity and diabetes Diabet. Care 27 2004 596 601
10. P. Dandona, R. Weinstock, K. Thusu, E. Abdel-Rahman, A. Aljada, and T. Wadden Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss J. Clin. Endocrinol. Metab. 83 1998 2907 2910
11. L. Di Renzo, M. Bigioni, V. Del Gobbo, M.G. Premrov, U. Barbini, and N. Di Lorenzo Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels Pharmacol. Res. 55 2007 131 138
12. U. Eder, B. Mangweth, C. Ebenbichler, E. Weiss, A. Hofer, and M. Hummer Association of olanzapine-induced weight gain with an increase in body fat Am. J. Psychiatry 158 2001 1719 1722
13. J. Fernø, A.O. Vik-Mo, G. Jassim, B. Havik, K. Berge, and S. Skrede Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver Psychopharmacology (Berl) 203 2009 73 84
14. K.M. Gadde, W. Zhang, and M.S. Foust Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial J. Clin. Psychopharmacol. 26 2006 409 413
15. D. Georgescu, R.M. Sears, J.D. Hommel, M. Barrot, C.A. Bolanos, and D.J. Marsh The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance J. Neurosci. 25 2005 2933 2940
16. M. Guerre-Millo Adipose tissue and adipokines: for better or worse Diabetes Metab. 30 2004 13 19
17. S.M. Hsu, and L. Raine Protein A, avidin, and biotin in immunohistochemistry J. Histochem. Cytochem. 29 1981 1349 1353
18. A. Katsuki, Y. Sumida, S. Murashima, K. Murata, Y. Takarada, and K. Ito Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus J. Clin. Endocrinol. Metab. 83 1998 859 862
19. Y.K. Kim, A.M. Myint, R. Verkerk, S. Scharpe, H. Steinbusch, and B. Leonard Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients Neuropsychobiology 59 2009 123 129
20. M. Kluge, A. Schuld, A. Schacht, H. Himmerich, M.A. Dalal, and P.M. Wehmeier Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever Psychoneuroendocrinology 34 2009 118 128
21. M. Maes, E. Bosmans, R. Ranjan, E. Vandoolaeghe, H.Y. Meltzer, and M. De Ley Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs Schizophr. Res. 21 1996 39 50
22. M. Maes, E. Bosmans, G. Kenis, R. De Jong, R.S. Smith, and H.Y. Meltzer In vivo immunomodulatory effects of clozapine in schizophrenia Schizophr. Res. 26 1997 221 225
23. M. Maes, L. Bocchio Chiavetto, S. Bignotti, G.J. Battisa Tura, R. Pioli, and F. Boin Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor Schizophr. Res. 54 2002 281 291
24. J.M. Meyer, J.P. McEvoy, V.G. Davis, D.C. Goff, H.A. Nasrallah, and S.M. Davis Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study Biol. Psychiatry 66 2009 1013 1022
25. J. Minet-Ringuet, P.C. Even, B. Guesdon, D. Tomé, and R. de Beaurepaire Effects of chronic neuroleptic treatments on nutrient selection, body weight, and body composition in the male rat under dietary self-selection Behav. Brain Res. 163 2005 204 211
26. J. Minet-Ringuet, P.C. Even, M. Lacroix, D. Tomé, and R. de Beaurepaire A model for antipsychotic-induced obesity in the male rat Psychopharmacology (Berl) 187 2006 447 454
27. J. Minet-Ringuet, P.C. Even, P. Valet, C. Carpéné, V. Visentin, and D. Prevot Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment Mol. Psychiatry 12 2007 562 571
28. W. Nefti, C. Chaumontet, G. Fromentin, D. Tomé, and N. Darcel A high-fat diet attenuates the central response to within-meal satiation signals and modifies the receptor expression of vagal afferents in mice Am. J. Physiol. 296 2009 R1681 1686
29. T.W. Pace, T.C. Mletzko, O. Alagbe, D.L. Musselman, C.B. Nemeroff, and A.H. Miller Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress Am. J. Psychiatry 163 2006 1630 1633
30. D.A. Pappas, J.M. Bathon, D. Hanicq, U. Yasothan, and P. Kirkpatrick Golimumab. Nature Rev. Drug Discov. 8 2009 695 696
31. T. Pollmächer, D. Hinze-Selch, and J. Mullington Effects of clozapine on plasma cytokine and soluble cytokine receptor levels J. Clin. Psychopharmacol. 16 1996 403 409
32. T. Pollmächer, D. Hinze-Selch, T. Fenzel, T. Kraus, A. Schuld, and J. Mullington Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol Am. J. Psychiatry 154 1997 1763 1765
33. S. Potvin, E. Stip, A.A. Sepehry, A. Gendron, R. Bah, and E. Kouassi Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review Biol. Psychiatry 63 2008 801 808
34. M.B. Raeder, J. Fernø, A.O. Vik-Mo, and V.M. Steen SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Mol Cell Biochem. 289 2006 167 173
35. R.S. Smith, and M. Maes The macrophage-T-lymphocyte theory of schizophrenia: additional evidence Med. Hypotheses 45 1995 135 141
36. L.F. Van Gaal, I.L. Mertens, and C.E. De Block Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880
37. H.S. Vestri, L. Maianu, D.R. Moellering, and W.T. Garvey Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis Neuropsychopharmacology 32 2007 765 772
38. M. Victoriano, D. Hermier, P.C. Even, G. Fromentin, J.F. Huneau, and D. Tomé Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats Psychopharmacology (Berl) 206 2009 167 176
39. A.O. Vik-Mo, J. Fernø, S. Skrede, and V.M. Steen Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells BMC Pharmacol. 9 2009 10
40. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796 1808
41. L.H. Yang, T.M. Chen, S.T. Yu, and Y.H. Chen Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells Pharmacol. Res. 56 2007 202 208
42. X.Y. Zhang, L.Y. Cao, C. Song, G.Y. Wu, C. Chen da, and L.Y. Qi Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics Psychopharmacology (Berl) 201 2008 383 389